Innovative Medtech Total Debt vs. Market Capitalization

IMTH -  USA Stock  

USD 0.28  0.00  0.00%

For Innovative Medtech profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Innovative Medtech to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Innovative Medtech utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Innovative Medtech's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Innovative Medtech over time as well as its relative position and ranking within its peers. Please see Risk vs Return Analysis.

Innovative Current Profitability Trends 

 
Refresh
Is Innovative Medtech's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Innovative Medtech. If investors know Innovative will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Innovative Medtech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Innovative Medtech is measured differently than its book value, which is the value of Innovative that is recorded on the company's balance sheet. Investors also form their own opinion of Innovative Medtech's value that differs from its market value or its book value, called intrinsic value, which is Innovative Medtech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Innovative Medtech's market value can be influenced by many factors that don't directly affect Innovative Medtech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Innovative Medtech's value and its price as these two are different measures arrived at by different means. Investors typically determine Innovative Medtech value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Innovative Medtech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Innovative Medtech Market Capitalization vs. Total Debt Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Innovative Medtech's current stock value. Our valuation model uses many indicators to compare Innovative Medtech value to that of its competitors to determine the firm's financial worth.
Innovative Medtech is rated below average in total debt category among related companies. It is rated below average in market capitalization category among related companies creating about  0.02  of Market Capitalization per Total Debt. The ratio of Total Debt to Market Capitalization for Innovative Medtech is roughly  47.22 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Innovative Medtech by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Innovative Medtech's OTC Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Innovative Medtech's earnings, one of the primary drivers of an investment's value.

Innovative Total Debt vs. Competition

Innovative Medtech is rated below average in total debt category among related companies. Total debt of Medical Instruments & Supplies industry is currently estimated at about 84.97 Billion. Innovative Medtech adds roughly 2.24 Million in total debt claiming only tiny portion of all equities under Medical Instruments & Supplies industry.
Total debt  Valuation  Workforce  Capitalization  Revenue

Innovative Market Capitalization vs. Total Debt

Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Innovative Medtech 
Total Debt 
 = 
Bonds 
+  
Notes 
2.24 M
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Innovative Medtech 
Market Cap 
 = 
Shares Outstanding 
X  
Share Price 
47.44 K
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.

Innovative Market Capitalization vs Competition

Innovative Medtech is rated below average in market capitalization category among related companies. Market capitalization of Medical Instruments & Supplies industry is currently estimated at about 515.08 Billion. Innovative Medtech adds roughly 47,440 in market capitalization claiming only tiny portion of all equities under Medical Instruments & Supplies industry.
Capitalization  Total debt  Workforce  Valuation  Revenue

Innovative Medtech Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Innovative Medtech, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Innovative Medtech will eventually generate negative long term returns. The profitability progress is the general direction of Innovative Medtech's change in net profit over the period of time. It can combine multiple indicators of Innovative Medtech, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Innovative MedTech Inc., through its subsidiaries, provides health and wellness services in the United States. Innovative MedTech Inc. was incorporated in 2005 and is based in Blue Island, Illinois. Innovative Medtech operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 37 people.

Innovative Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Innovative Medtech. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Innovative Medtech position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Innovative Medtech's important profitability drivers and their relationship over time.

Use Innovative Medtech in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Innovative Medtech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innovative Medtech will appreciate offsetting losses from the drop in the long position's value.

Innovative Medtech Pair Trading

Innovative Medtech Pair Trading Analysis

Correlation analysis and pair trading evaluation for Innovative Medtech and Essilor Intl. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  

Use Investing Themes to Complement your Innovative Medtech position

In addition to having Innovative Medtech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Trump Equities Thematic Idea Now

Trump Equities
Trump Equities Theme
Stocks that have significantly increased in valuation since Trump was elected president of the United States. Trump Equities theme has 42 constituents.
View All  Next Launch Trump Equities
Please see Risk vs Return Analysis. Note that the Innovative Medtech information on this page should be used as a complementary analysis to other Innovative Medtech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Search module to search for activelly traded equities including funds and ETFs from over 30 global markets.

Complementary Tools for Innovative OTC Stock analysis

When running Innovative Medtech price analysis, check to measure Innovative Medtech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innovative Medtech is operating at the current time. Most of Innovative Medtech's value examination focuses on studying past and present price action to predict the probability of Innovative Medtech's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Innovative Medtech's price. Additionally, you may evaluate how the addition of Innovative Medtech to your portfolios can decrease your overall portfolio volatility.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
To fully project Innovative Medtech's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Innovative Medtech at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Innovative Medtech's income statement, its balance sheet, and the statement of cash flows.
Potential Innovative Medtech investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Innovative Medtech investors may work on each financial statement separately, they are all related. The changes in Innovative Medtech's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Innovative Medtech's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.